HomeProductsBioactive CompoundsEndocrine & Hormonal TargetsERRArzoxifene
Chemical structure of CAS 182133-25-1

Arzoxifene

CAS No.182133-25-1
MDL No.N/A
MFC28H29NO4S
MW475.60
InChI KeyMCGDSOGUHLTADD-UHFFFAOYSA-N

Pricing & Availability

Pack SizePurityPriceAvailabilityAction
- -On RequestOn Request
Custom synthesis and bulk supply options are available upon request.

Product Information

CAS No.182133-25-1
Product NameArzoxifene

Biological Targets

ESR2·ESR1

Associated Conditions

ovarian cancer·breast cancer·endometrial cancer·postmenopausal osteoporosis·breast neoplasm·
* The information provided here is compiled from public sources and is for reference only.

Related Articles

Studies related to this compound and its mechanism of action

Effects of oral estrogen, raloxifene and arzoxifene on gene expression in serotonin neurons of macaques.

Psychoneuroendocrinology • Vol. 27, Issue 4 • 2002
PMID: 11911997DOI: 10.1016/s0306-4530(01)00054-3

SERMs: current status and future trends.

Critical reviews in oncology/hematology • Vol. 43, Issue 1 • 2002
PMID: 12098608DOI: 10.1016/s1040-8428(02)00022-7

Novel therapeutic options for osteoporosis.

Current opinion in rheumatology • Vol. 14, Issue 4 • 2002
PMID: 12118183DOI: 10.1097/00002281-200207000-00020

Breast cancer chemoprevention: beyond tamoxifen.

Breast cancer research : BCR • Vol. 3, Issue 2 • 2001
PMID: 11250754PMC: PMC139439DOI: 10.1186/bcr279

Documentation

Similar Products